Find the answer.Keep moving forward.

Trimi's annual plan is $99/month for compounded semaglutide, billed $1,188 once yearly, or $125/month for compounded tirzepatide, billed $1,500 once yearly. Both annual plans are a 12-month commitment. The monthly figure is the annual price divided by 12, not a monthly charge. Plans include medication if prescribed, provider consultations, ongoing support and free overnight shipping once compounded. Shorter plans cost more per month; review the billing and refund terms before paying.

Complete the online health questionnaire, which takes about 5-10 minutes. A licensed provider reviews your information and may request more details. A prescription is not assured. If prescribed, your medication is prepared and shipped by a state-licensed pharmacy.

Medication ships free overnight once compounded. Signup to delivery typically takes 2-4 days, including provider review and pharmacy preparation. Review, fulfillment and delivery times vary; this is an estimate rather than a promised date.

Your billing term matters. Turning off renewal does not automatically cancel or refund a prepaid term. The annual plan is a 12-month commitment. Contact the care team to request a change and obtain confirmation, and review the refund policy for cancellation, medical ineligibility and the conditional 6-month money-back policy.

No. Compounded semaglutide is not FDA-approved. FDA does not review compounded drugs for safety, effectiveness or quality before marketing. A licensed pharmacy's compounded preparation is distinct from an FDA-approved finished drug.

Existing patients can use the patient portal for provider and care-team messaging. The Contact page also lists phone, email and sign-in help. Portal access at any time does not mean an immediate reply. For an emergency, call 911 rather than using a support message.

Trimi starts with an online health questionnaire. A licensed provider reviews your history and decides whether treatment is appropriate. If prescribed, a state-licensed pharmacy prepares your medication, which ships free overnight once compounded. Ongoing provider messaging is included.

Check the dispensing pharmacy's identity, state license and the instructions on your prescription label. Trimi works with VialsRx (Texas pharmacy license #35264) and GreenwichRx. Ask the pharmacy or care team about available testing documentation and contact them before injecting if the label or dose is unclear. A test report does not establish FDA approval or remove all medication risks.

FDA-approved branded products have undergone FDA review as finished drugs. Compounded preparations are made per individual prescription by state-licensed pharmacies and are not FDA-approved. Formulation, concentration, packaging and instructions can differ. Do not substitute or convert doses without provider and pharmacist guidance.

Use the instructions for your specific prescription, concentration and syringe. Milligrams and syringe units measure different things; do not guess a conversion or reuse another person's instructions. Ask your provider or dispensing pharmacist to confirm the dose and demonstrate the technique if anything is unclear before your first injection.

Trimi's plans are cash-pay. Insurance reimbursement and HSA/FSA expense eligibility depend on your plan administrator. Ask what documentation is required before paying. A letter or accepted payment does not establish reimbursement or eligibility. Annual plans have full upfront charges and a 12-month commitment; compare billing terms in the cost guide.

Price alone cannot establish legitimacy or quality. Check the named clinical network, pharmacy license, billing terms and current certification record. Trimi publishes its clinical leadership, pharmacy partners and review policies so you can investigate them before starting.

Trimi's program considers adults with a BMI of 22 or higher with a weight-related condition, or a BMI of 30 or higher. BMI alone does not determine eligibility. Your provider reviews your health history, medications and other relevant factors to decide whether treatment is appropriate.

The shipment schedule depends on your selected plan and the pharmacy's preparation schedule. Longer prepaid terms do not necessarily mean the entire term ships at once. Check your plan details and the pharmacy's beyond-use date and storage directions; ask the care team about your next delivery.

Your shipment includes your prescribed medication and the supplies and directions for that prescription. Check the package against the pharmacy's instructions. Contact the care team about missing supplies or unclear directions before taking a dose. Shipping is free overnight once compounded, and you can access provider messaging through the patient portal.

Trimi offers compounded semaglutide and compounded tirzepatide, prescribed only where clinically appropriate and prepared per individual prescription by state-licensed pharmacies. Compounded medications are not FDA-approved.

Semaglutide acts on GLP-1 receptors; tirzepatide acts on GLP-1 and GIP receptors. That distinction alone does not tell you which is appropriate for you. Your provider considers your medical history, current medications and response. Results from branded-drug trials do not establish outcomes for Trimi's compounded preparations.

These treatments are prescribed as once-weekly injections. Follow the dose, injection technique and storage instructions supplied with your specific prescription. Ask your provider or pharmacist about anything unclear rather than changing the dose or schedule yourself.

Treatment duration is an individual clinical decision. Discuss benefits, side effects and a longer-term plan with your provider. Your medical treatment plan and your prepaid billing term are separate considerations; review both before making changes.

Tell your provider about your response and any side effects. They may reassess the treatment or recommend a clinically appropriate change. Do not increase the dose yourself. Review your billing and refund terms with the care team if treatment is changed or stopped.

Trimi's published plans are cash-pay and do not bill insurance. Ask your insurer or HSA/FSA administrator about any reimbursement and documentation requirements before paying.

Trimi offers monthly, quarterly, 6-month and annual billing terms. Longer prepaid terms have different rates. If a payment provider offers installments during checkout, its terms are separate from your Trimi plan; installments do not turn an annual commitment into a monthly plan.

Shipping cadence depends on the selected plan and the pharmacy's preparation schedule. Check your plan details or ask the care team about recurring deliveries. Medication ships free overnight once compounded; timing can vary.

Nausea, diarrhea, vomiting, constipation and abdominal discomfort can occur. Discuss persistent or concerning symptoms with your provider. Severe symptoms, dehydration or an allergic reaction need prompt medical attention; read the important safety information for additional warnings.

Individual responses vary. Your provider can discuss realistic goals and monitor your progress. Trials of branded medications studied specific formulations, doses and populations; their averages are not a prediction for you or evidence of results with Trimi's compounded preparations.

Discuss nutrition, activity and other health goals with your provider so the plan fits your needs and abilities. Medication does not replace a broader care plan, and no particular amount of weight loss is assured.

Weight regain can occur after stopping treatment. Discuss a maintenance plan and any change in medication with your provider. Continued care, nutrition and activity should be individualized; no maintenance outcome is assured.

Use the patient portal for care-related communication. The privacy policy explains how information may be used or disclosed and how to exercise your rights. Contact the care team about a privacy concern; avoid sending sensitive health details through public comments or social media.

STEP 1 studied weekly semaglutide 2.4 mg plus lifestyle intervention in 1,961 adults over 68 weeks. Mean weight change was -14.9% with semaglutide versus -2.4% with placebo. This research evaluated the study drug, not Trimi's compounded preparations, and does not predict an individual's response.

SURMOUNT-1 studied tirzepatide in 2,539 adults over 72 weeks. Mean weight reductions were 15.0%, 19.5% and 20.9% at the 5, 10 and 15 mg doses, respectively, versus 3.1% with placebo. These study-drug results do not establish outcomes for Trimi's compounded preparations.

SELECT studied semaglutide 2.4 mg in adults aged 45 or older with established cardiovascular disease, overweight or obesity, and no diabetes. Major cardiovascular events occurred in 6.5% of the semaglutide group versus 8.0% with placebo, a 20% relative reduction. This does not establish cardiovascular benefit for compounded semaglutide or for people outside that study population.

Branded semaglutide and tirzepatide labeling lists a personal or family history of medullary thyroid carcinoma, MEN 2 and serious hypersensitivity among contraindications. Other conditions may require caution or make treatment inappropriate. Tell your provider about your full history, pregnancy or breastfeeding, current medicines and any planned procedure. Do not use a FAQ to self-determine eligibility.

Rates depend on the drug, dose and study population. The Wegovy injection label reports nausea in 44% of adults receiving 2.4 mg versus 16% with placebo in its pooled weight-reduction trials. That is a branded-product study result, not a measured Trimi rate. Contact your provider about troublesome symptoms.

Trimi names its dispensing partners, including VialsRx (Texas pharmacy license #35264) and GreenwichRx. You can check a pharmacy's current license with the relevant state board and ask it about preparation and testing documentation. State licensure is not FDA approval of a compounded medication.

Combining these treatments with insulin or a sulfonylurea can increase the risk of low blood sugar. Your prescriber may need to change your treatment or monitoring. Do not adjust insulin or other medicines yourself; review your full medication list with your provider.

Acute pancreatitis is a labeled warning. Seek urgent medical advice for persistent severe abdominal pain, including pain that extends to the back, with or without vomiting. A history of pancreatitis needs individual provider assessment; it is not interchangeable with a formal contraindication.

Weight-loss treatment should not be used during pregnancy. Contact your provider promptly if pregnant or planning pregnancy. Breastfeeding requires a medicine-specific discussion with your provider; recommendations and available evidence differ by formulation. Do not assume the same restriction or washout interval applies to every product.

Your provider starts with an appropriate dose and adjusts it gradually based on the prescription, your response and tolerability. Do not accelerate the schedule or change syringe units yourself. Ask your provider or dispensing pharmacist to confirm the dose whenever concentration or instructions change.

Your provider reviews your health history and current medications and may request lab results or additional evaluation when clinically needed. Ask the care team what is required for your situation and whether additional costs apply. A questionnaire alone does not assure approval.

Trimi connects patients with clinical care through Arora Health and works with named state-licensed pharmacy partners. A provider licensed in the patient's state reviews each prescription. Review the clinical profiles, medical-review policy and pharmacy information, and check current credentials with the relevant source.

Compare the full amount charged, billing commitment, included services, clinical network and dispensing pharmacy. Trimi publishes its own plan terms and named clinical and pharmacy partners. The cost guide explains the actual payment schedule so you can compare plans on consistent terms.

The Arora Health provider network operates across all 50 US states. Your provider must be licensed in your state, and treatment remains subject to individual clinical review and applicable dispensing requirements. Confirm current availability for your location during the online visit.